Grossman DC, Curry SJ, Owens DK, . Screening for ovarian cancer: US Preventive Services Task Force recommendation statement. JAMA 2018;319:588–594.
Terplan M, Schluterman N, McNamara EJ, . Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 2012;125:19–24.
Motzer RJ, Jonasch E, Agarwal N, . Ovarian cancer, Version 2. 2014: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2014;12:175–181.
Bristow RE, Chang J, Ziogas A, . Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 2013;121:1226–1234.
Bristow RE, Chang J, Ziogas A, . Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol 2014;134:60–67.
Bristow RE, Chang J, Ziogas A, . Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol 2015;125:833–842.
Bristow RE, Chang J, Ziogas A, . Spatial analysis of advanced-stage ovarian cancer mortality in California. Am J Obstet Gynecol 2015;213:43.e1–43.e8.
Hodeib M, Chang J, Liu F, . Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol 2015;138:121–127.
Collins Y, Holcomb K, Chapman-Davis E, . Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 2014;133:353–361.
Cronin KA, Howlader N, Stevens JL, . Racial disparities in the receipt of guideline care and cancer deaths for women with ovarian cancer. Cancer Epidemiol Biomarkers Prev 2019;28:539–545.
Bristow RE, Powell MA, Al-Hammadi N, . Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 2013;105:823–832.
Long B, Chang J, Ziogas A, . Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California. Am J Obstet Gynecol 2015;212:468.e1–468.e9.
Fairfield KM, Lucas FL, Earle CC, . Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer 2010;116:4840–4848.
Dehaeck U, McGahan CE, Santos JL, . The impact of geographic variations in treatment on outcomes in ovarian cancer. Int J Gynecol Cancer 2013;23:282–287.
Stewart SL, Cooney D, Hirsch S, . The effect of gynecologic oncologist availability on ovarian cancer mortality. World J Obstet Gynecol 2014;3:71–77.
Tracey E, Hacker NF, Young J, . Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study. Int J Gynecol Cancer 2014;24:1232–1240.
Cowan RA, O’Cearbhaill RE, Gardner GJ, . Is it time to centralize ovarian cancer care in the United States? Ann Surg Oncol 2016;23:989–993.
Galvan-Turner VB, Chang J, Ziogas A, . Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer. Gynecol Oncol 2015;139:495–499.
Bristow RE, Zahurak ML, Diaz-Montes TP, . Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol 2009;115:334–338.
Polsky D, Armstrong KA, Randall TC, . Variations in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res 2006;41:2201–2218.
Bristow RE, Chang J, Ziogas A, . High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol 2014;132:403–410.
Chase DM, Fedewa S, Chou TS, . Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy? Obstet Gynecol 2012;119:68–77.
Wasif N, Chang YH, Pockaj BA, . Association of distance traveled for surgery with short- and long-term cancer outcomes. Ann Surg Oncol 2016;23:3444–3452.
American Cancer Society. Cancer Statistics Center. Ovary. Available at: https://cancerstatisticscenter.cancer.org/?_ga=2.71867859.1377176935.1542797564-800158735.1542797564#!/cancer-site/Ovary. Accessed October 2, 2019.
Parikh-Patel A, Allen M, Wright WE. Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol 2003;157:539–545.
California Cancer Registry. Information for patients. Available at: https://www.ccrcal.org/learn-about-ccr/about-cancer-registries/information-for-patients/#how%20complete%20are%20ccr%20data. Accessed June 7, 2019.
Morgan RJ Jr, Alvarez RD, Armstrong DK, . Ovarian cancer, version 3.2012. J Natl Compr Canc Netw 2012;10:1339–1349.
Morgan RJ Jr, Alvarez RD, Armstrong DK, . Ovarian cancer, version 2.2013. J Natl Compr Canc Netw 2013;11:1199–1209.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
Lichtensztajn DY, Giddings BM, Morris CR, . Comorbidity index in central cancer registries: the value of hospital discharge data. Clin Epidemiol 2017;9:601–609.
Yost K, Perkins C, Cohen R, . Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703–711.
Yang J, Schupp CW, Harrati A, . Developing an Area-based Socioeconomic Measure From American Community Survey Data. Fremont, CA: Cancer Prevention Institute of California; 2014.
Hastie T, Tibshirani R. Generalized Additive Models. Boca Raton, FL: Chapman & Hall/CRC Press; 1990.
Webster T, Vieira V, Weinberg J, . Method for mapping population-based case-control studies: an application using generalized additive models. Int J Health Geogr 2006;5:26.
Erickson BK, Martin JY, Shah MM, . Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center. Gynecol Oncol 2014;133:142–146.
- Search Google Scholar
- Export Citation
)| false . , Erickson BK , Martin JY , Shah MM Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center. 2014; 133: 142– 146. 10.1016/j.ygyno.2014.02.006 24517876
Visser BC, Ma Y, Zak Y, . Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB 2012;14:539–547.
Pfaendler KS, Chang J, Ziogas A, . Disparities in adherence to National Comprehensive Cancer Network treatment guidelines and survival for stage IB-IIA cervical cancer in California. Obstet Gynecol 2018;131:899–908.
Boulos DN, Ghali RR, Ibrahim EM, . An eight-year snapshot of geospatial cancer research (2002-2009): clinico-epidemiological and methodological findings and trends. Med Oncol 2011;28:1145–1162.
Reames BN, Ghaferi AA, Birkmeyer JD, . Hospital volume and operative mortality in the modern era. Ann Surg 2014;260:244–251.
Barrington DA, Dilley SE, Landers EE, . Distance from a comprehensive cancer center: a proxy for poor cervical cancer outcomes? Gynecol Oncol 2016;143:617–621.
Temkin SM, Fleming SA, Amrane S, . Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center. Gynecol Oncol 2015;137:497–502.
Guagliardo MF. Spatial accessibility of primary care: concepts, methods and challenges. Int J Health Geogr 2004;3:3.
Shalowitz DI, Nivasch E, Burger RA, . Are patients willing to travel for better ovarian cancer care? Gynecol Oncol 2018;148:42–48.
Jindal M, Zheng C, Quadri HS, . Why do long-distance travelers have improved pancreatectomy outcomes? J Am Coll Surg 2017;225:216–225.
Bristow RE, Palis BE, Chi DS, . The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010;118:262–267.
- Search Google Scholar
- Export Citation
)| false . , Bristow RE , Palis BE , Chi DS The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. 2010; 118: 262– 267. 20573392 10.1016/j.ygyno.2010.05.025
Jones AP, Haynes R, Sauerzapf V, . Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer 2008;44:992–999.
Goff BA, Matthews BJ, Larson EH, . Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 2007;109:2031–2042.